Suppr超能文献

脑静脉和静脉窦血栓形成后再通的频率及时间分布

Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis.

作者信息

Herweh C, Griebe M, Geisbüsch C, Szabo K, Neumaier-Probst E, Hennerici M G, Bendszus M, Ringleb P A, Nagel S

机构信息

Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany.

Department of Neurology, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.

出版信息

Eur J Neurol. 2016 Apr;23(4):681-7. doi: 10.1111/ene.12901. Epub 2015 Nov 19.

Abstract

BACKGROUND AND PURPOSE

The temporal course of recanalization and its association with clinical outcome were analysed in our patients with cerebral sinus and/or venous thrombosis (CSVT) and follow-up magnetic resonance imaging (MRI).

METHODS

Between January 1998 and September 2014 all patients from our institutions with CSVT were systematically analysed. Baseline data, treatment characteristics and follow-up MRI were retrospectively recorded. The status of recanalization was assessed as complete (CRec), partial (PRec) or failed recanalization. Clinical follow-up was measured with the modified Rankin Scale. Excellent outcome was defined as modified Rankin Scale 0-1.

RESULTS

Ninety-nine patients were identified; 97% of these patients were treated with oral anticoagulation (OAC) and the median (min-max) time of OAC was 7 months (1-84). CRec was achieved in 57.6% (57/99), PRec in 29.3% (29/99) and only 13 (13.1%) patients did not recanalize. The median (min-max) time to PRec was 4 months (0.25-14) and to CRec 6 months (2-34). Median time to last clinical follow-up was 8 months (1-88); 91.8% (89/99) had an excellent outcome at last clinical follow-up and only 2.1% (2/99) died. Only thrombosis of the superior sagittal sinus was independently associated with successful recanalization (odds ratio 16, 95% confidence interval 2-138). No severe haemorrhagic complications and no recurrence of CSVT occurred within clinical follow-up. No association of outcome and recanalization status was found.

CONCLUSIONS

The recanalization rate of CSVT under OAC was high and the median time to CRec was 6 months. Thrombosis of the superior sagittal sinus is a positive predictor of recanalization. Outcome in this cohort was excellent but no significant association of outcome and recanalization status was found.

摘要

背景与目的

我们对患有脑静脉窦和/或静脉血栓形成(CSVT)的患者进行了再通的时间进程分析及其与临床结局的关联,并进行了随访磁共振成像(MRI)检查。

方法

对1998年1月至2014年9月期间我们机构中所有患有CSVT的患者进行系统分析。回顾性记录基线数据、治疗特征和随访MRI。再通状态评估为完全再通(CRec)、部分再通(PRec)或再通失败。采用改良Rankin量表进行临床随访。良好结局定义为改良Rankin量表评分为0 - 1分。

结果

共确定99例患者;其中97%的患者接受了口服抗凝治疗(OAC),OAC的中位(最小 - 最大)时间为7个月(1 - 84个月)。57.6%(57/99)实现了完全再通,29.3%(29/99)为部分再通,仅13例(13.1%)患者未再通。达到部分再通的中位(最小 - 最大)时间为4个月(0.25 - 14个月),达到完全再通的时间为6个月(2 - 34个月)。最后一次临床随访的中位时间为8个月(1 - 88个月);91.8%(89/99)在最后一次临床随访时结局良好,仅2.1%(2/99)死亡。仅上矢状窦血栓形成与成功再通独立相关(比值比16,95%置信区间2 - 138)。临床随访期间未发生严重出血并发症,也未出现CSVT复发。未发现结局与再通状态之间存在关联。

结论

OAC治疗下CSVT的再通率较高,达到完全再通的中位时间为6个月。上矢状窦血栓形成是再通的阳性预测指标。该队列的结局良好,但未发现结局与再通状态之间存在显著关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验